The results, combined with those from a kinetic study, led us to identify and validate coumestrol as a novel CK2 kinase inhibitor. To the best of our knowledge, our study is the first to show that coumestrol is a CK2 kinase inhibitor in both cell-free assay and cancer cells. The ...